Almirall Ltd

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2024	1	Value not published	1
2023	3	Value not published	3

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierAlmirall Ltd

Source records

Published awards

5 records linked to this supplier.

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Buyer: NHS England
End date in notice
31 Aug 2026
Value shown in notice
£688,010,000Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-9914c3d5-bf44-4fbc-a2e3-258a048efd52 / ocds-b5fd17-9914c3d5-bf44-4fbc-a2e3-258a048efd52-1
NHS National Generic Pharmaceuticals Wave 14b
Buyer: ATAMIS LTD

Almirall Ltd

Published records by year

Buyer relationships by value counted

Published awards

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS National Generic Pharmaceuticals Wave 14b

NHS South of England Branded Medicines - Tranche A - September 2023

NHS London Branded Medicines - Tranche B - September 2023

NP90726l Tildrakizumab (Ilumetri®)